Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah M E Gabriele

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
JAMA|September 15, 2023
The Problem of Limited-Supply Agreements for Medicare Price NegotiationSarah M E Gabriele, William B Feldman
JAMA|November 21, 2024
Characteristics of Academic Inventors on Government-Linked US Drug PatentsMatthew J Martin, Sarah M E Gabriele, Aaron S Kesselheim, et al.
Nature Biotechnology|December 2, 2025
Gabriele et al. replySarah M E Gabriele, Matthew J Martin, Aaron S Kesselheim, et al.
Nature Biotechnology|July 15, 2025
The strength and importance of government-funded patents for approved drugsSarah M E Gabriele, Matthew J Martin, Aaron S Kesselheim, et al.
JAMA Internal Medicine|May 13, 2024
Patent Portfolios Protecting 10 Top-Selling Prescription DrugsCaroline Horrow, Sarah M E Gabriele, S Sean Tu, et al.
JAMA Health Forum|January 2, 2026
Tertiary Patents on Drugs Approved by the FDATheodore W Teng, S Sean Tu, Helen Mooney, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
JAMA|September 15, 2023
The Problem of Limited-Supply Agreements for Medicare Price NegotiationSarah M E Gabriele, William B Feldman
JAMA|November 21, 2024
Characteristics of Academic Inventors on Government-Linked US Drug PatentsMatthew J Martin, Sarah M E Gabriele, Aaron S Kesselheim, et al.
Nature Biotechnology|December 2, 2025
Gabriele et al. replySarah M E Gabriele, Matthew J Martin, Aaron S Kesselheim, et al.
Nature Biotechnology|July 15, 2025
The strength and importance of government-funded patents for approved drugsSarah M E Gabriele, Matthew J Martin, Aaron S Kesselheim, et al.
JAMA Internal Medicine|May 13, 2024
Patent Portfolios Protecting 10 Top-Selling Prescription DrugsCaroline Horrow, Sarah M E Gabriele, S Sean Tu, et al.
JAMA Health Forum|January 2, 2026
Tertiary Patents on Drugs Approved by the FDATheodore W Teng, S Sean Tu, Helen Mooney, et al.
Pageof 1